Coegin Pharma (NGM:COEGIN) ROCE % : -294.73% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Coegin Pharma ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Coegin Pharma's annualized ROCE % for the quarter that ended in Dec. 2023 was -294.73%.

Coegin Pharma ROCE % Historical Data

The historical data trend for Coegin Pharma's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coegin Pharma ROCE % Chart

Coegin Pharma Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-61.01

-486.80

-147.59

-170.47

-201.19

Coegin Pharma Quarterly Data
	Dec18	Mar19	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-169.13	-102.80	-105.14	-158.00	-294.73

Coegin Pharma ROCE % Calculation

Coegin Pharma's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-27.931	/	( ( (29.246 - 8.232)	+	(15.433 - 8.681) )	/ 2 )
	=	-27.931	/	( (21.014	+	6.752)	/ 2 )
	=	-27.931	/	13.883
	=	-201.19 %

Coegin Pharma's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-31.544	/	( ( (17.409 - 2.756)	+	(15.433 - 8.681) )	/ 2 )
	=	-31.544	/	( ( 14.653	+	6.752 )	/ 2 )
	=	-31.544	/	10.7025
	=	-294.73 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Coegin Pharma (NGM:COEGIN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Coegin Pharma ROCE % Related Terms

Thank you for viewing the detailed overview of Coegin Pharma's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Coegin Pharma (NGM:COEGIN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Coegin Pharma (NGM:COEGIN) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Birger Jarlsgatan 18 A, 4th Floor, Stockholm, SWE, 114 34

Website

https://www.coeginpharma.com

Coegin Pharma AB is a biotechnology company that focuses on the development of small molecule therapies for the treatment of inflammatory diseases such as cancer and kidney disease.

Coegin Pharma (NGM:COEGIN) Headlines

No Headlines